查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1836796

全球非血管支架市场按应用、产品类型、材料类型和最终用户划分—预测至 2025 年至 2032 年

Non-vascular Stents Market by Application, Product Type, Material Type, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年非血管支架市场将成长至 23.1 亿美元，复合年增长率为 7.47%。

主要市场统计数据
基准年2024年 13亿美元
预计2025年 14亿美元
预测年份：2032年 23.1亿美元
复合年增长率（%） 7.47%

全面介绍非血管支架，重点在于临床应用、技术发展以及影响各专业应用的策略驱动因素

随着临床医生和器械製造商应对日益增多的临床适应症和不断发展的手术标准，非血管支架已成为介入医学的重要组成部分。这些器械可治疗各种非血管腔内病变，提供机械支撑，维持通畅性，并支持在气道、胆道、胃肠道和泌尿系统系统进行微创手术。随着手术的日益复杂化、跨学科协作以及向门诊病人和流动医疗环境的转变，非血管支架的应用也随之增加。在这些环境中，器械的性能和易用性对临床工作流程和病患週转量有重大影响。

近期的技术进步，包括合金冶金、聚合物涂层和输送系统的改进，降低了併发症率并延长了器械的使用寿命。因此，越来越多的临床医生选择支架进行复杂的解剖结构和可重复的干预。同时，医疗保健系统也优先考虑能够减少住院时间和再入院率的工具，因此产品价值的评判标准也越来越多地不仅取决于其直接的临床效果，还取决于其对资源利用的下游影响。多个司法管辖区的监管途径已经成熟，明确了市场准入和上市后监管的证据阈值，这反过来又影响着製造商的投资策略。

不断变化的医疗模式和日益严格的付款人审查意味着公司必须将器械性能与清晰的健康经济叙事相结合。拥有可靠临床数据、精简物流以及与采购相关人员进行战术性互动的製造商将最有能力影响处方和操作指南。总而言之，非血管支架的前景由技术进步、跨专业操作的普及以及日益增长的将临床价值与系统级结果相结合的需求所决定。

重大的技术、程序和循证转变将重新定义非血管支架采用的设备设计、临床路径和采购优先级

近年来，医疗体系中非血管支架的设计、评估和部署再形成发生了变革性的变化。首先，材料创新已超越渐进式变革，能够针对特定的解剖和病理情况提供客製化解决方案。合金工程和镍钛合金加工如今支持更高的径向力和顺应性，而聚合物材料则为生物整合和药物输送提供了替代策略，为辅助性治疗开闢了新的可能性。

其次，微创技术在各专业的普及重塑了手术路径。肺科、胃肠科和泌尿系统等专业越来越多地使用影像引导、内视镜和混合方法，因此需要优化输送系统以提高精准度并减少创伤。因此，器械设计也更以使用者为中心，强调易于实施、缩短手术时间以及与现有手术设施的兼容性。

第三，医疗保健服务模式正转向门诊和门诊，在这些情况下，吞吐量和可预测的结果决定了购买决策。这种转变迫使製造商改善灭菌、包装和物流，以满足门诊手术中心的要求。最后，真实世界证据正在加速将真实世界证据纳入监管和付款人对话。真实世界註册和实用研究正在补充对照试验，以展示比较表现和经济影响，为临床医生的偏好和报销讨论提供资讯。总而言之，这些转变表明，未来的竞争力将取决于将临床有效性、营运效率和可证明的经济价值相结合的综合解决方案。

2025 年的关税将如何重塑供应链、製造地和采购行为，并对医疗设备经济和准入产生长期影响？

2025年美国关税的征收和提高，将对非血管支架製造商、经销商和临床服务提供者产生一系列复杂的下游影响。关税政策给进口原材料和成品器械带来了额外的成本压力，并波及到供应链谈判、库存策略以及与医疗保健系统的定价谈判。重要的是，关税已促使许多公司重新评估供应商多元化和近岸外包作为稳定投入成本和前置作业时间的机制。

为了因应关税带来的成本变化，製造商采取了多种战术性应对措施。一些製造商加快了製造和组装的本地化进程，以减轻进口关税的影响；其他製造商则探索了关税分类和合规策略，以限制关税负担。这些选择会影响资本配置和位置选择，以及监理备案和品质体系协调。经销商和医院正在调整采购顺序，增加安全库存，并延长合约谈判，以纳入保护利润和业务连续性的关税应急条款。

除了直接的财务影响之外，关税也改变了竞争动态。拥有一体化本地供应链的国内製造商在某些产品类型中获得了相对价格优势，这使得它们能够更积极地与大型医疗系统签订合约。相反，依赖全球采购的小型供应商面临利润率压缩，导致它们优先考虑更高价值的SKU和策略伙伴关係。在临床方面，采购相关人员正在加强对医疗总成本（而不仅仅是单位成本）的审查，并要求生命週期成本、再干预率和服务合约的透明度。整体而言，2025年的关税环境正在推动供应链重组，影响策略投资决策，并提升弹性采购和差异化价值提案的重要性。

策略性细分洞察，将临床应用、产品类型、材料和最终用户动态映射到可操作的商业化优先事项

对于寻求将产品开发和商业策略与临床实际情况相结合的相关人员来说，细緻入微地理解细分市场至关重要。按应用分析，市场涵盖呼吸道、胆道、胃肠道和泌尿系统道，其中呼吸道细分市场进一步细分为支气管和气管管段，胃肠道细分市场进一步细分为结肠、十二指肠和食道应用。泌尿系统同样分为前列腺、输尿管和尿道应用，每种应用都有不同的解剖挑战、临床终点和手术流程，进而影响器械的几何形状、径向强度和输送机制。

产品类型区分球囊扩张型和自扩张型，这决定了部署技术、辅助成像需求以及与弯曲或动态管腔的兼容性。镍钛合金具有超弹性和顺应性，聚合物具有生物降解特性和药物释放型机会，不銹钢则具有传统的性能特征和成本优势。最终用户细分区分了门诊手术中心和医院，这对包装、灭菌标准、存货周转和销售管道参与度具有战略意义。

综上所述，这些细分领域构成了一个由临床、营运和商业性变数组成的矩阵，企业必须应对这些变数。产品团队必须将器械规格与特定的解剖和手术需求相匹配，而商业领导者则必须根据门诊和住院采购环境的实际情况，客製化通讯和定价。此外，研发优先顺序必须在材料创新与法规可追溯性和製造扩充性之间取得平衡，以确保新产品能够满足不同的临床需求和系统级需求。

应对部署非血管支架的主要全球市场的监管复杂性、采购行为和临床多样性的区域策略

区域动态对监管途径、采购行为和临床应用模式有着重大影响，因此需要在全球市场制定差异化策略。美洲地区呈现出一个多元化的环境，先进的临床能力和多样化的付款人模式并存。监管期望强调临床证据以支持上市后监督和报销谈判，而采购决策通常由机构层级的委员会和基于价值的合约安排驱动。

在欧洲、中东和非洲，相关人员面临着错综复杂的国家法规结构和预算压力，这些因素凸显了成本效益和结果数据的重要性。亚太地区融合了先进的医疗保健系统和快速崛起的市场，需求多种多样，从高复杂性的设备需求到成本敏感型解决方案，以及支援区域生产和分销策略的製造生态系统和供应链节点。

这些地区共同挑战製造商，他们需要在全球生命週期管理与区域特定情报之间取得平衡。上市计划必须纳入监管时机、报销途径以及反映当地临床实践和采购文化的策略伙伴关係关係。此外，供应链设计和商业模式必须适应区域物流、製造能力和医疗保健系统的优先事项，以确保在不同地区实现永续的采用和可扩展的成长。

竞争格局分析揭示了现有企业、专业创新者和区域参与企业如何在临床证据、物流和商业模式方面竞争

非血管支架市场的竞争动态反映出现有医疗设备公司、专业创新企业和新兴区域企业的混合，它们各自寻求不同的临床应用和市场渗透路径。现有企业专注于整合的产品组合、强大的分销网络，以及将器械与服务和培训项目捆绑销售的能力，从而减少手术差异并促进临床医生的采用。这些现有企业通常会投资长期证据产生和指引参与，以巩固临床偏好。

相较之下，专业创新者瞄准的是利基解剖或手术挑战，并专注于技术差异化，例如新型材料科学、混合药物-器械组合以及针对复杂几何形状优化的输送系统。这类公司经常利用早期临床合作伙伴关係和研究者主导的临床实验来检验产品效能，并获得关键意见领袖的支持。区域製造商和新参与企业在成本和本地监管灵活性方面展开竞争，在成本敏感型市场提供可行的替代方案，并利用与区域供应链的便利性来缩短前置作业时间。

无论竞争如何，成功的公司都会将临床开发与清晰的经济叙事相结合，并引起医院管理者和门诊手术中心的共鸣。此外，通路策略至关重要。直销模式可以促进更紧密的临床医生参与和上市后支持，而分销商伙伴关係则可以在分散的市场中加速覆盖。最终，那些兼具临床信誉、供应链韧性以及针对目标细分市场诊疗流程和采购实际情况的商业模式的公司将获得竞争优势。

製造商应优先采取的行动包括确保临床可靠性、加强供应链，并使商业策略与不断发展的医疗保健服务模式保持一致

产业领导者必须果断行动，将技术潜力转化为可持续的市场地位。首先，製造商应优先制定符合付款方和监管机构期望的临床证据策略，并投资于可操作的註册研究和现实世界研究，以证明其在再介入、住院时间和整体手术成本方面取得了显着降低。这些证据将有助于医院处方集的纳入和基于价值的合约谈判。

其次，应将供应链韧性提升至策略重点。企业应实现采购多元化，考虑关键零件近岸外包，并制定能够应对关税波动和物流中断的库存策略。同时，商业团队应针对门诊手术中心和医院量身市场开发方法，客製化服务产品、培训计画和产品包装，以应对不同的营运限制。投资临床医生教育和流程标准化可以减少差异性并加速采用。

第三，产品蓝图应在材料创新与可製造性和法规可追溯性之间取得平衡，优先考虑能够弥补明确流程差距的增量临床效益。研发、法规和商业团队之间的跨职能协作可以加快产品上市时间并确保市场相关性。最后，领导者应探索策略伙伴关係和选择性併购，以增强在药物释放型技术、聚合物科学或区域製造方面的能力。执行这些优先事项将使公司能够在竞争日益激烈的环境中建立差异化并保持成长。

严格的混合方法研究方法结合了临床医生访谈、监管和临床证据综合以及供应链分析，确保了可操作和检验的见解

本研究整合了主要和次要研究，包括临床文献、监管申报、器械註册和相关人员访谈，旨在全面了解非血管支架的市场格局。主要研究包括对介入临床医生、采购负责人和监管专家的结构化访谈，以了解手术趋势、证据预期和购买行为。这些定性见解与临床试验数据、同行评审出版物和公开的监管文件进行了三角检验，以确认技术准确性和临床相关性。

二级资讯来源包括製造商产品资讯、器械附加檔说明书以及专业协会指南，以阐明器械特性和建议用法。透过进出口数据、材料采购报告以及与物流供应商的访谈，分析了供应链和製造方面的洞察，以评估其脆弱性和营运策略。分析方法包括定性资料的主题编码、跨多项研究的临床结果交叉检验以及情境分析，以评估关税和供应链突发事件。为了保持调查方法的严谨性并与决策者相关，关键研究结果由专家检验，以确保与临床实际情况和商业性影响相符。

全面回顾这些结论，强调了技术创新、证据生成和营运弹性的整合，这将决定非血管支架相关人员的长期成功。

非血管支架正在从一系列独立的器械类别转变为一个互联互通的领域，材料科学、输送技术和医疗保健系统优先事项的交汇决定了其临床和商业性成功。该市场的特点是越来越重视可证实的患者疗效、门诊和医院的营运效率，以及能够承受地缘政治和关税相关压力的灵活供应链。这些因素将为那些将可靠的临床证据与务实的生产和分销策略相结合的组织带来回报。

展望未来，针对特定解剖挑战的差异化材料和以用户为中心的输送系统的竞争将愈演愈烈，而监管和支付方格局将优先考虑实际性能和成本效益。积极将研发投资与报销要求相结合，并建立伙伴关係关係以扩大临床检验的组织将塑造实践模式和采购选择。最终，非血管支架领域的成功将取决于能否将创新转化为可衡量的系统级价值，并执行能够满足临床医生、患者和医疗保健系统买家需求的弹性商业化策略。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

  • 开发生物可吸收聚合物气管支架以减少长期併发症
  • 将药物释放型技术整合到气道支架中，以最大限度地减少肉芽组织的形成
  • 利用 3D 列印技术製作患者专用食道支架，解决复杂的解剖变异
  • 形状记忆合金气管支架的进步提高了部署的准确性和一致性
  • 泌尿系统支架抗菌涂层的投资正在增加，以对抗生物膜相关感染疾病
  • 下一代消化器官系统产品 CE 标誌监管进展加速市场进入

第六章：2025年美国关税的累积影响

第七章：人工智慧的累积影响，2025年

8. 非血管支架市场（依应用）

  • 呼吸道
    • 支气管
    • 气管
  • 胆汁
  • 消化器官系统
    • 冒号
    • 十二指肠
    • 食道
  • 泌尿系统
    • 摄护腺
    • 输尿管
    • 尿道

9. 非血管支架市场（依产品类型）

  • 球囊扩张
  • 自膨胀

第 10 章非血管支架市场（依材料类型）

  • 镍钛合金
  • 聚合物
  • 不銹钢

第 11 章非血管支架市场（依最终用户）

  • 门诊手术中心
  • 医院

12. 非血管支架市场（按地区）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章非血管支架市场（依类别）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

14. 非血管支架市场（依国家）

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章竞争格局

  • 2024年市占率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • Boston Scientific Corporation
    • Medtronic plc
    • Abbott Laboratories
    • Becton, Dickinson and Company
    • Cook Medical LLC
    • B. Braun Melsungen AG
    • Merit Medical Systems, Inc.
    • Teleflex Incorporated
    • Endo International plc
    • Taewoong Medical Co., Ltd.
Product Code: MRR-036C5CF3B534

The Non-vascular Stents Market is projected to grow by USD 2.31 billion at a CAGR of 7.47% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 1.30 billion
Estimated Year [2025] USD 1.40 billion
Forecast Year [2032] USD 2.31 billion
CAGR (%) 7.47%

A comprehensive orientation to non-vascular stents highlighting clinical breadth, technological evolution, and the strategic drivers shaping adoption across specialties

Non-vascular stents now occupy a pivotal role in interventional medicine as clinicians and device manufacturers respond to expanding clinical indications and evolving procedural standards. These devices address an array of luminal pathologies beyond the vascular system, providing mechanical support, maintaining patency, and enabling minimally invasive approaches across airway, biliary, gastrointestinal, and urological domains. Adoption is driven by increasing procedural sophistication, cross-specialty collaboration, and a shift toward outpatient and ambulatory care settings where device performance and ease of deployment materially affect clinical workflow and patient throughput.

Recent technological refinements, such as improvements in alloy metallurgy, polymer coatings, and delivery systems, have reduced complication rates and improved device longevity. As a result, clinicians are more willing to select stents for complex anatomies and repeatable interventions. Concurrently, health systems are prioritizing tools that reduce length of stay and rehospitalization, so product value is judged not only by immediate clinical efficacy but also by impact on downstream resource utilization. Regulatory pathways have matured in several jurisdictions, clarifying evidence thresholds for market access and post-market surveillance, which in turn shapes manufacturer investment strategies.

Transitioning care models and intensifying scrutiny from payers mean that companies must align device performance with clear health economic narratives. Manufacturers who combine robust clinical data with streamlined logistics and tactical engagement with procurement stakeholders will be best positioned to influence formularies and procedural guidelines. In sum, the non-vascular stents landscape is defined by technical progress, procedural diffusion across specialties, and the increasing necessity of aligning clinical value with system-level outcomes.

Major technological, procedural, and evidence-based shifts that are redefining device design, clinical pathways, and procurement priorities in non-vascular stent adoption

The recent period has witnessed transformative shifts reshaping how non-vascular stents are designed, evaluated, and deployed within health systems. First, material innovation has progressed beyond incremental changes to enable purpose-built solutions for specific anatomical and pathological contexts. Alloy engineering and nitinol processing now support enhanced radial force and conformability while polymeric materials offer alternative strategies for biointegration and drug delivery, opening new opportunities for adjunctive therapies.

Second, procedural pathways have realigned as minimally invasive techniques proliferate across specialties. Interventional pulmonology, gastroenterology, and urology increasingly adopt image-guided, endoscopic, and combined hybrid approaches, which in turn demand delivery systems optimized for precision and reduced trauma. Consequently, device design has become more user-centric, focusing on ease of deployment, reduced procedure time, and compatibility with existing procedural suites.

Third, healthcare delivery models are shifting care toward ambulatory and outpatient settings where throughput and predictable outcomes drive purchasing decisions. This shift compels manufacturers to refine sterilization, packaging, and logistics to meet ambulatory surgical center requirements. Lastly, the integration of real-world evidence into regulatory and payer conversations has accelerated. Real-world registries and pragmatic studies now supplement controlled trials to demonstrate comparative performance and economic impact, informing clinician preference and reimbursement discussions. Collectively, these shifts emphasize that future competitiveness will depend on integrated solutions that combine clinical efficacy, operational efficiency, and demonstrable economic value.

How 2025 tariff measures are reshaping supply chains, manufacturing footprints, and procurement behaviors with long-term implications for device economics and access

The imposition and escalation of tariffs by the United States in 2025 have created a complex set of downstream effects for manufacturers, distributors, and clinical providers engaged with non-vascular stents. Tariff policy has introduced incremental cost pressures on imported raw materials and finished devices, which in turn reverberate through supply chain negotiations, inventory strategies, and pricing conversations with health systems. Importantly, tariffs have also prompted many organizations to re-evaluate supplier diversity and nearshoring as mechanisms to stabilize input costs and lead times.

In response to tariff-driven cost volatility, manufacturers have pursued several tactical responses. Some have accelerated localization of manufacturing and assembly operations to mitigate exposure to import duties, while others have sought tariff classifications and compliance strategies to limit duty burdens. These choices affect capital allocation and site selection, with implications for regulatory filings and quality system harmonization. Distributors and hospitals have adjusted procurement cadence, increasing safety stock and extending contract negotiations to incorporate tariff contingency clauses that protect margins and operational continuity.

Beyond direct financial effects, tariffs have shifted competitive dynamics. Domestic producers with integrated local supply chains have gained relative pricing advantage in certain product categories, enabling more aggressive contracting with large health systems. Conversely, smaller suppliers reliant on global sourcing have faced compressed margins and have prioritized higher-value SKUs or strategic partnerships. On the clinical side, purchasing stakeholders have heightened scrutiny of total cost of care rather than unit price alone, seeking transparency on lifecycle costs, reintervention rates, and service agreements. Overall, the tariff environment in 2025 has catalyzed supply chain reconfiguration, influenced strategic investment decisions, and increased the importance of resilient sourcing and differentiated value propositions.

Strategic segmentation insights that map clinical applications, product types, materials, and end-user dynamics to actionable commercialization priorities

A nuanced understanding of segmentation is essential for stakeholders seeking to align product development and commercial strategies with clinical realities. When analyzed by application, the market spans airway, biliary, gastrointestinal, and urological indications, with the airway category further disaggregated into bronchial and tracheal subsegments and the gastrointestinal category further parsed into colorectal, duodenal, and esophageal uses. The urological domain likewise differentiates into prostatic, ureteral, and urethral applications, each presenting distinct anatomical challenges, clinical endpoints, and procedural workflows that influence device geometry, radial strength, and delivery mechanisms.

Product type delineation separates balloon-expandable devices from self-expanding constructs, a distinction that informs deployment technique, requirement for adjunctive imaging, and suitability for tortuous or dynamic lumens. Material type remains a foundational axis of differentiation, as nitinol imparts superelasticity and conformability, polymeric solutions offer alternative biodegradation profiles and drug elution opportunities, and stainless steel provides legacy performance characteristics and cost considerations. End-user segmentation distinguishes ambulatory surgical centers from hospitals, and this distinction carries strategic implications for packaging, sterilization standards, inventory turnover, and sales channel engagement.

Taken together, these segmentation lenses produce a matrix of clinical, operational, and commercial variables that companies must navigate. Product teams should map device specifications to specific anatomical and procedural needs, while commercial leaders must tailor messaging and pricing to the procurement realities of ambulatory versus inpatient settings. In addition, R&D prioritization should balance material innovations with regulatory tractability and manufacturing scalability to ensure that new offerings address discrete clinical gaps and system-level requirements.

Regional strategies that reconcile regulatory complexity, procurement behaviors, and clinical diversity across major global markets for non-vascular stent deployment

Regional dynamics exert a profound influence on regulatory pathways, procurement behavior, and clinical adoption patterns, requiring differentiated strategies across global markets. The Americas region presents a heterogeneous environment where advanced clinical capabilities coexist with diverse payer models; regulatory expectations emphasize post-market surveillance and clinical evidence that supports reimbursement negotiations, while procurement decisions often hinge on institution-level committees and value-based contracting arrangements.

In Europe, Middle East & Africa, stakeholders encounter a mosaic of national regulatory frameworks and budgetary pressures that elevate the importance of cost-effectiveness and outcomes data; localized clinical practice variations and national procurement policies necessitate tailored market access approaches and country-level evidence generation. Asia-Pacific encompasses both advanced healthcare systems and rapidly developing markets, yielding a spectrum of needs from high-complexity device demand to cost-sensitive solutions, with manufacturing ecosystems and supply chain nodes that can support regional production and distribution strategies.

Collectively, these regions demand that manufacturers balance global lifecycle management with localized intelligence. Market entry plans should incorporate regulatory timing, reimbursement pathways, and strategic partnerships that reflect regional clinical practice and procurement culture. Moreover, supply chain design and commercial models must adapt to regional logistics, manufacturing capabilities, and health system priorities to ensure sustainable adoption and scalable growth across distinct geographic contexts.

Competitive landscape analysis revealing how incumbents, specialized innovators, and regional entrants compete on clinical evidence, logistics, and commercial models

Competitive dynamics in the non-vascular stents space reflect a mix of established medical device firms, specialized innovators, and emerging regional players, each pursuing different pathways to clinical adoption and market penetration. Established firms emphasize integrated portfolios, robust distribution networks, and the ability to bundle devices with service offerings and training programs that reduce procedural variability and accelerate clinician uptake. These incumbents often invest in long-term evidence generation and guideline engagement to solidify clinical preference.

Specialized innovators, by contrast, target niche anatomical or procedural challenges with focused technological differentiation-such as novel material science, hybrid drug-device combinations, or delivery systems optimized for complex geometries. These firms frequently leverage early clinical partnerships and investigator-initiated studies to validate performance and to build key opinion leader support. Regional manufacturers and new entrants compete on cost and local regulatory agility, offering pragmatic alternatives in cost-sensitive markets and exploiting proximity to regional supply chains to shorten lead times.

Across competitor types, successful companies align clinical development with clear economic narratives that speak to hospital administrators and ambulatory surgical centers alike. Additionally, channel strategy matters: direct sales models can foster closer clinician engagement and post-market support, while distributor partnerships can accelerate reach in fragmented markets. Ultimately, competitive advantage will accrue to organizations that combine clinical credibility, supply chain resilience, and commercial models tailored to the procedural and procurement realities of their target segments.

Actionable priorities for manufacturers to secure clinical credibility, strengthen supply chains, and align commercial strategies with evolving care delivery models

Industry leaders must act decisively to convert technological promise into durable market positions while mitigating operational and regulatory risks. First, manufacturers should prioritize clinical evidence strategies that align with payer and regulatory expectations, investing in pragmatic registries and real-world studies that demonstrate meaningful reductions in reintervention, length of stay, and overall procedural cost. This evidence will support both hospital formulary inclusion and value-based contracting conversations.

Second, supply chain resilience should be elevated to a strategic priority. Companies ought to diversify sourcing, consider nearshoring for critical components, and build inventory strategies that account for tariff volatility and logistics disruptions. Concurrently, commercial teams must tailor go-to-market approaches for ambulatory surgical centers and hospitals, customizing service offerings, training programs, and packaging to meet differing operational constraints. Investing in clinician education and procedural standardization will reduce variability and accelerate adoption.

Third, product roadmaps should balance material innovation with manufacturability and regulatory tractability, favoring incremental clinical gains that address well-defined procedural gaps. Cross-functional alignment among R&D, regulatory, and commercial teams will accelerate time-to-market and ensure market-fit. Finally, leaders should explore strategic partnerships and selective M&A to expand capabilities in drug-eluting technologies, polymer science, or regional manufacturing capacity. By executing on these priorities, companies can create defensible differentiation and sustain growth in an increasingly competitive landscape.

Rigorous mixed-method research approach combining clinician interviews, regulatory and clinical evidence synthesis, and supply chain analysis to ensure actionable and validated insights

This research synthesizes primary and secondary inputs across clinical literature, regulatory filings, device registries, and stakeholder interviews to construct a comprehensive view of the non-vascular stents landscape. Primary research included structured interviews with interventional clinicians, procurement leaders, and regulatory experts to capture procedural trends, evidence expectations, and purchasing behaviors. These qualitative insights were triangulated with analyses of clinical trial data, peer-reviewed publications, and publicly available regulatory documents to ensure technical accuracy and clinical relevance.

Secondary sources encompassed manufacturer product information, device labeling, and professional society guidelines to contextualize device features and recommended usage. Supply chain and manufacturing considerations were analyzed through import/export data, materials sourcing reports, and interviews with logistics providers to assess vulnerabilities and operational strategies. Analytical methods included thematic coding of qualitative data, cross-validation of clinical outcomes from multiple studies, and scenario analysis to evaluate tariff and supply chain contingencies. Throughout, an iterative review process ensured alignment between clinical realities and commercial implications, and subject-matter experts validated key findings to maintain methodological rigor and relevance for decision-makers.

Concluding synthesis highlighting the convergence of innovation, evidence generation, and operational resilience that will determine long-term success for non-vascular stent stakeholders

Non-vascular stents are transitioning from a set of discrete device categories into an interconnected domain where material science, delivery technology, and health system priorities intersect to determine clinical and commercial success. The market is characterized by heightened emphasis on demonstrable patient outcomes, operational efficiency in ambulatory and hospital settings, and adaptive supply chains that can withstand geopolitical and tariff-related pressures. These forces will reward organizations that integrate robust clinical evidence with pragmatic manufacturing and distribution strategies.

Looking forward, competition will intensify around differentiated materials and user-centric delivery systems that address specific anatomical challenges, while regulatory and payer landscapes will prioritize real-world performance and cost-effectiveness. Organizations that proactively align R&D investment with reimbursement imperatives and that cultivate partnerships to extend clinical validation will shape practice patterns and procurement choices. In conclusion, success in the non-vascular stents domain will hinge on the ability to translate technical innovation into measurable system-level value and to execute resilient commercialization strategies that meet the needs of clinicians, patients, and health system buyers.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Increasing development of bioresorbable polymer tracheal stents to reduce long-term complications
  • 5.2. Integration of drug-eluting technology in airway stents to minimize granulation tissue formation
  • 5.3. Use of 3D printing for patient-specific esophageal stents addressing complex anatomical variations
  • 5.4. Advancements in shape-memory alloy tracheal stents improving deployment precision and conformability
  • 5.5. Growing investment in antimicrobial coatings on urological stents to combat biofilm-associated infections
  • 5.6. Regulatory progress in CE marking of next-generation gastrointestinal non-vascular stents enabling faster market access

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Non-vascular Stents Market, by Application

  • 8.1. Airway
    • 8.1.1. Bronchial
    • 8.1.2. Tracheal
  • 8.2. Biliary
  • 8.3. Gastrointestinal
    • 8.3.1. Colorectal
    • 8.3.2. Duodenal
    • 8.3.3. Esophageal
  • 8.4. Urological
    • 8.4.1. Prostatic
    • 8.4.2. Ureteral
    • 8.4.3. Urethral

9. Non-vascular Stents Market, by Product Type

  • 9.1. Balloon-Expandable
  • 9.2. Self-Expanding

10. Non-vascular Stents Market, by Material Type

  • 10.1. Nitinol
  • 10.2. Polymeric
  • 10.3. Stainless Steel

11. Non-vascular Stents Market, by End User

  • 11.1. Ambulatory Surgical Center
  • 11.2. Hospitals

12. Non-vascular Stents Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Non-vascular Stents Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Non-vascular Stents Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Boston Scientific Corporation
    • 15.3.2. Medtronic plc
    • 15.3.3. Abbott Laboratories
    • 15.3.4. Becton, Dickinson and Company
    • 15.3.5. Cook Medical LLC
    • 15.3.6. B. Braun Melsungen AG
    • 15.3.7. Merit Medical Systems, Inc.
    • 15.3.8. Teleflex Incorporated
    • 15.3.9. Endo International plc
    • 15.3.10. Taewoong Medical Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL NON-VASCULAR STENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS NON-VASCULAR STENTS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA NON-VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA NON-VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA NON-VASCULAR STENTS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE NON-VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST NON-VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA NON-VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC NON-VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN NON-VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC NON-VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION NON-VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS NON-VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 NON-VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO NON-VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NON-VASCULAR STENTS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. NON-VASCULAR STENTS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. NON-VASCULAR STENTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL NON-VASCULAR STENTS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL NON-VASCULAR STENTS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY AIRWAY, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY AIRWAY, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY AIRWAY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY AIRWAY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY AIRWAY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY AIRWAY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY AIRWAY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY AIRWAY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY BRONCHIAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY BRONCHIAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY BRONCHIAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY BRONCHIAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY BRONCHIAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY BRONCHIAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY TRACHEAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY TRACHEAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY TRACHEAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY TRACHEAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY TRACHEAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY TRACHEAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY BILIARY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY BILIARY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY BILIARY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY BILIARY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY BILIARY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY BILIARY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY COLORECTAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY COLORECTAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY COLORECTAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY COLORECTAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY COLORECTAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY COLORECTAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY DUODENAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY DUODENAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY DUODENAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY DUODENAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY DUODENAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY DUODENAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY ESOPHAGEAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY ESOPHAGEAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY ESOPHAGEAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY ESOPHAGEAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY ESOPHAGEAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY ESOPHAGEAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY UROLOGICAL, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY UROLOGICAL, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY UROLOGICAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY UROLOGICAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY UROLOGICAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY UROLOGICAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY UROLOGICAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY UROLOGICAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY PROSTATIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY PROSTATIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY PROSTATIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY PROSTATIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY PROSTATIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY PROSTATIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY URETERAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY URETERAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY URETERAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY URETERAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY URETERAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY URETERAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY URETHRAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY URETHRAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY URETHRAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY URETHRAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY URETHRAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY URETHRAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY BALLOON-EXPANDABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY BALLOON-EXPANDABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY BALLOON-EXPANDABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY BALLOON-EXPANDABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY BALLOON-EXPANDABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY BALLOON-EXPANDABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY SELF-EXPANDING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY SELF-EXPANDING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY SELF-EXPANDING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY SELF-EXPANDING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY SELF-EXPANDING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY SELF-EXPANDING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY NITINOL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY NITINOL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY NITINOL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY NITINOL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY NITINOL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY NITINOL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY POLYMERIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY POLYMERIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY POLYMERIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY POLYMERIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY POLYMERIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY POLYMERIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. AMERICAS NON-VASCULAR STENTS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 136. AMERICAS NON-VASCULAR STENTS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 137. AMERICAS NON-VASCULAR STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 138. AMERICAS NON-VASCULAR STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 139. AMERICAS NON-VASCULAR STENTS MARKET SIZE, BY AIRWAY, 2018-2024 (USD MILLION)
  • TABLE 140. AMERICAS NON-VASCULAR STENTS MARKET SIZE, BY AIRWAY, 2025-2032 (USD MILLION)
  • TABLE 141. AMERICAS NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL, 2018-2024 (USD MILLION)
  • TABLE 142. AMERICAS NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL, 2025-2032 (USD MILLION)
  • TABLE 143. AMERICAS NON-VASCULAR STENTS MARKET SIZE, BY UROLOGICAL, 2018-2024 (USD MILLION)
  • TABLE 144. AMERICAS NON-VASCULAR STENTS MARKET SIZE, BY UROLOGICAL, 2025-2032 (USD MILLION)
  • TABLE 145. AMERICAS NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 146. AMERICAS NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 147. AMERICAS NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 148. AMERICAS NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 149. AMERICAS NON-VASCULAR STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 150. AMERICAS NON-VASCULAR STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA NON-VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. NORTH AMERICA NON-VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA NON-VASCULAR STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 154. NORTH AMERICA NON-VASCULAR STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA NON-VASCULAR STENTS MARKET SIZE, BY AIRWAY, 2018-2024 (USD MILLION)
  • TABLE 156. NORTH AMERICA NON-VASCULAR STENTS MARKET SIZE, BY AIRWAY, 2025-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL, 2018-2024 (USD MILLION)
  • TABLE 158. NORTH AMERICA NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL, 2025-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA NON-VASCULAR STENTS MARKET SIZE, BY UROLOGICAL, 2018-2024 (USD MILLION)
  • TABLE 160. NORTH AMERICA NON-VASCULAR STENTS MARKET SIZE, BY UROLOGICAL, 2025-2032 (USD MILLION)
  • TABLE 161. NORTH AMERICA NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 162. NORTH AMERICA NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 163. NORTH AMERICA NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 164. NORTH AMERICA NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 165. NORTH AMERICA NON-VASCULAR STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 166. NORTH AMERICA NON-VASCULAR STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA NON-VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. LATIN AMERICA NON-VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. LATIN AMERICA NON-VASCULAR STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 170. LATIN AMERICA NON-VASCULAR STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 171. LATIN AMERICA NON-VASCULAR STENTS MARKET SIZE, BY AIRWAY, 2018-2024 (USD MILLION)
  • TABLE 172. LATIN AMERICA NON-VASCULAR STENTS MARKET SIZE, BY AIRWAY, 2025-2032 (USD MILLION)
  • TABLE 173. LATIN AMERICA NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL, 2018-2024 (USD MILLION)
  • TABLE 174. LATIN AMERICA NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL, 2025-2032 (USD MILLION)
  • TABLE 175. LATIN AMERICA NON-VASCULAR STENTS MARKET SIZE, BY UROLOGICAL, 2018-2024 (USD MILLION)
  • TABLE 176. LATIN AMERICA NON-VASCULAR STENTS MARKET SIZE, BY UROLOGICAL, 2025-2032 (USD MILLION)
  • TABLE 177. LATIN AMERICA NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 178. LATIN AMERICA NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 179. LATIN AMERICA NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 180. LATIN AMERICA NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 181. LATIN AMERICA NON-VASCULAR STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 182. LATIN AMERICA NON-VASCULAR STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA NON-VASCULAR STENTS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA NON-VASCULAR STENTS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA NON-VASCULAR STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 186. EUROPE, MIDDLE EAST & AFRICA NON-VASCULAR STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 187. EUROPE, MIDDLE EAST & AFRICA NON-VASCULAR STENTS MARKET SIZE, BY AIRWAY, 2018-2024 (USD MILLION)
  • TABLE 188. EUROPE, MIDDLE EAST & AFRICA NON-VASCULAR STENTS MARKET SIZE, BY AIRWAY, 2025-2032 (USD MILLION)
  • TABLE 189. EUROPE, MIDDLE EAST & AFRICA NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL, 2018-2024 (USD MILLION)
  • TABLE 190. EUROPE, MIDDLE EAST & AFRICA NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL, 2025-2032 (USD MILLION)
  • TABLE 191. EUROPE, MIDDLE EAST & AFRICA NON-VASCULAR STENTS MARKET SIZE, BY UROLOGICAL, 2018-2024 (USD MILLION)
  • TABLE 192. EUROPE, MIDDLE EAST & AFRICA NON-VASCULAR STENTS MARKET SIZE, BY UROLOGICAL, 2025-2032 (USD MILLION)
  • TABLE 193. EUROPE, MIDDLE EAST & AFRICA NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 194. EUROPE, MIDDLE EAST & AFRICA NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 195. EUROPE, MIDDLE EAST & AFRICA NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 196. EUROPE, MIDDLE EAST & AFRICA NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA NON-VASCULAR STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA NON-VASCULAR STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 199. EUROPE NON-VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. EUROPE NON-VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. EUROPE NON-VASCULAR STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 202. EUROPE NON-VASCULAR STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 203. EUROPE NON-VASCULAR STENTS MARKET SIZE, BY AIRWAY, 2018-2024 (USD MILLION)
  • TABLE 204. EUROPE NON-VASCULAR STENTS MARKET SIZE, BY AIRWAY, 2025-2032 (USD MILLION)
  • TABLE 205. EUROPE NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL, 2018-2024 (USD MILLION)
  • TABLE 206. EUROPE NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL, 2025-2032 (USD MILLION)
  • TABLE 207. EUROPE NON-VASCULAR STENTS MARKET SIZE, BY UROLOGICAL, 2018-2024 (USD MILLION)
  • TABLE 208. EUROPE NON-VASCULAR STENTS MARKET SIZE, BY UROLOGICAL, 2025-2032 (USD MILLION)
  • TABLE 209. EUROPE NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 210. EUROPE NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 211. EUROPE NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 212. EUROPE NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 213. EUROPE NON-VASCULAR STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 214. EUROPE NON-VASCULAR STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST NON-VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 216. MIDDLE EAST NON-VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 217. MIDDLE EAST NON-VASCULAR STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 218. MIDDLE EAST NON-VASCULAR STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 219. MIDDLE EAST NON-VASCULAR STENTS MARKET SIZE, BY AIRWAY, 2018-2024 (USD MILLION)
  • TABLE 220. MIDDLE EAST NON-VASCULAR STENTS MARKET SIZE, BY AIRWAY, 2025-2032 (USD MILLION)
  • TABLE 221. MIDDLE EAST NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL, 2018-2024 (USD MILLION)
  • TABLE 222. MIDDLE EAST NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL, 2025-2032 (USD MILLION)
  • TABLE 223. MIDDLE EAST NON-VASCULAR STENTS MARKET SIZE, BY UROLOGICAL, 2018-2024 (USD MILLION)
  • TABLE 224. MIDDLE EAST NON-VASCULAR STENTS MARKET SIZE, BY UROLOGICAL, 2025-2032 (USD MILLION)
  • TABLE 225. MIDDLE EAST NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 226. MIDDLE EAST NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 227. MIDDLE EAST NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 228. MIDDLE EAST NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 229. MIDDLE EAST NON-VASCULAR STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 230. MIDDLE EAST NON-VASCULAR STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 231. AFRICA NON-VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 232. AFRICA NON-VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 233. AFRICA NON-VASCULAR STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 234. AFRICA NON-VASCULAR STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 235. AFRICA NON-VASCULAR STENTS MARKET SIZE, BY AIRWAY, 2018-2024 (USD MILLION)
  • TABLE 236. AFRICA NON-VASCULAR STENTS MARKET SIZE, BY AIRWAY, 2025-2032 (USD MILLION)
  • TABLE 237. AFRICA NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL, 2018-2024 (USD MILLION)
  • TABLE 238. AFRICA NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL, 2025-2032 (USD MILLION)
  • TABLE 239. AFRICA NON-VASCULAR STENTS MARKET SIZE, BY UROLOGICAL, 2018-2024 (USD MILLION)
  • TABLE 240. AFRICA NON-VASCULAR STENTS MARKET SIZE, BY UROLOGICAL, 2025-2032 (USD MILLION)
  • TABLE 241. AFRICA NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 242. AFRICA NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 243. AFRICA NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 244. AFRICA NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 245. AFRICA NON-VASCULAR STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 246. AFRICA NON-VASCULAR STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 247. ASIA-PACIFIC NON-VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 248. ASIA-PACIFIC NON-VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 249. ASIA-PACIFIC NON-VASCULAR STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 250. ASIA-PACIFIC NON-VASCULAR STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 251. ASIA-PACIFIC NON-VASCULAR STENTS MARKET SIZE, BY AIRWAY, 2018-2024 (USD MILLION)
  • TABLE 252. ASIA-PACIFIC NON-VASCULAR STENTS MARKET SIZE, BY AIRWAY, 2025-2032 (USD MILLION)
  • TABLE 253. ASIA-PACIFIC NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL, 2018-2024 (USD MILLION)
  • TABLE 254. ASIA-PACIFIC NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL, 2025-2032 (USD MILLION)
  • TABLE 255. ASIA-PACIFIC NON-VASCULAR STENTS MARKET SIZE, BY UROLOGICAL, 2018-2024 (USD MILLION)
  • TABLE 256. ASIA-PACIFIC NON-VASCULAR STENTS MARKET SIZE, BY UROLOGICAL, 2025-2032 (USD MILLION)
  • TABLE 257. ASIA-PACIFIC NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 258. ASIA-PACIFIC NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 259. ASIA-PACIFIC NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 260. ASIA-PACIFIC NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 261. ASIA-PACIFIC NON-VASCULAR STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 262. ASIA-PACIFIC NON-VASCULAR STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 265. ASEAN NON-VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 266. ASEAN NON-VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 267. ASEAN NON-VASCULAR STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 268. ASEAN NON-VASCULAR STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 269. ASEAN NON-VASCULAR STENTS MARKET SIZE, BY AIRWAY, 2018-2024 (USD MILLION)
  • TABLE 270. ASEAN NON-VASCULAR STENTS MARKET SIZE, BY AIRWAY, 2025-2032 (USD MILLION)
  • TABLE 271. ASEAN NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL, 2018-2024 (USD MILLION)
  • TABLE 272. ASEAN NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL, 2025-2032 (USD MILLION)
  • TABLE 273. ASEAN NON-VASCULAR STENTS MARKET SIZE, BY UROLOGICAL, 2018-2024 (USD MILLION)
  • TABLE 274. ASEAN NON-VASCULAR STENTS MARKET SIZE, BY UROLOGICAL, 2025-2032 (USD MILLION)
  • TABLE 275. ASEAN NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 276. ASEAN NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 277. ASEAN NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 278. ASEAN NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 279. ASEAN NON-VASCULAR STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 280. ASEAN NON-VASCULAR STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 281. GCC NON-VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 282. GCC NON-VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 283. GCC NON-VASCULAR STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 284. GCC NON-VASCULAR STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 285. GCC NON-VASCULAR STENTS MARKET SIZE, BY AIRWAY, 2018-2024 (USD MILLION)
  • TABLE 286. GCC NON-VASCULAR STENTS MARKET SIZE, BY AIRWAY, 2025-2032 (USD MILLION)
  • TABLE 287. GCC NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL, 2018-2024 (USD MILLION)
  • TABLE 288. GCC NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL, 2025-2032 (USD MILLION)
  • TABLE 289. GCC NON-VASCULAR STENTS MARKET SIZE, BY UROLOGICAL, 2018-2024 (USD MILLION)
  • TABLE 290. GCC NON-VASCULAR STENTS MARKET SIZE, BY UROLOGICAL, 2025-2032 (USD MILLION)
  • TABLE 291. GCC NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 292. GCC NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 293. GCC NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 294. GCC NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 295. GCC NON-VASCULAR STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 296. GCC NON-VASCULAR STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 297. EUROPEAN UNION NON-VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 298. EUROPEAN UNION NON-VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 299. EUROPEAN UNION NON-VASCULAR STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 300. EUROPEAN UNION NON-VASCULAR STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 301. EUROPEAN UNION NON-VASCULAR STENTS MARKET SIZE, BY AIRWAY, 2018-2024 (USD MILLION)
  • TABLE 302. EUROPEAN UNION NON-VASCULAR STENTS MARKET SIZE, BY AIRWAY, 2025-2032 (USD MILLION)
  • TABLE 303. EUROPEAN UNION NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL, 2018-2024 (USD MILLION)
  • TABLE 304. EUROPEAN UNION NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL, 2025-2032 (USD MILLION)
  • TABLE 305. EUROPEAN UNION NON-VASCULAR STENTS MARKET SIZE, BY UROLOGICAL, 2018-2024 (USD MILLION)
  • TABLE 306. EUROPEAN UNION NON-VASCULAR STENTS MARKET SIZE, BY UROLOGICAL, 2025-2032 (USD MILLION)
  • TABLE 307. EUROPEAN UNION NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 308. EUROPEAN UNION NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 309. EUROPEAN UNION NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 310. EUROPEAN UNION NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 311. EUROPEAN UNION NON-VASCULAR STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 312. EUROPEAN UNION NON-VASCULAR STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 313. BRICS NON-VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 314. BRICS NON-VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 315. BRICS NON-VASCULAR STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 316. BRICS NON-VASCULAR STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 317. BRICS NON-VASCULAR STENTS MARKET SIZE, BY AIRWAY, 2018-2024 (USD MILLION)
  • TABLE 318. BRICS NON-VASCULAR STENTS MARKET SIZE, BY AIRWAY, 2025-2032 (USD MILLION)
  • TABLE 319. BRICS NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL, 2018-2024 (USD MILLION)
  • TABLE 320. BRICS NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL, 2025-2032 (USD MILLION)
  • TABLE 321. BRICS NON-VASCULAR STENTS MARKET SIZE, BY UROLOGICAL, 2018-2024 (USD MILLION)
  • TABLE 322. BRICS NON-VASCULAR STENTS MARKET SIZE, BY UROLOGICAL, 2025-2032 (USD MILLION)
  • TABLE 323. BRICS NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 324. BRICS NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 325. BRICS NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 326. BRICS NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 327. BRICS NON-VASCULAR STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 328. BRICS NON-VASCULAR STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 329. G7 NON-VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 330. G7 NON-VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 331. G7 NON-VASCULAR STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 332. G7 NON-VASCULAR STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 333. G7 NON-VASCULAR STENTS MARKET SIZE, BY AIRWAY, 2018-2024 (USD MILLION)
  • TABLE 334. G7 NON-VASCULAR STENTS MARKET SIZE, BY AIRWAY, 2025-2032 (USD MILLION)
  • TABLE 335. G7 NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL, 2018-2024 (USD MILLION)
  • TABLE 336. G7 NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL, 2025-2032 (USD MILLION)
  • TABLE 337. G7 NON-VASCULAR STENTS MARKET SIZE, BY UROLOGICAL, 2018-2024 (USD MILLION)
  • TABLE 338. G7 NON-VASCULAR STENTS MARKET SIZE, BY UROLOGICAL, 2025-2032 (USD MILLION)
  • TABLE 339. G7 NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 340. G7 NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 341. G7 NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 342. G7 NON-VASCULAR STENTS MARKET SIZE, BY MATERIA